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We report a case of cryptococcosis due to C. gattii which appears to have been acquired in the Puget Sound
region, Washington State. Genotyping confirmed identity to the predominant Vancouver Island genotype. This
is the first documented case of human disease by the major Vancouver Island emergence strain acquired within
the United States.
In 2001, an emergence of Cryptococcus gattii on Vancouver
Island, British Columbia, Canada, was identified, with clinical
cases in both humans and other animals dating back to 1999 (2,
3, 7, 12). Environmental sampling identified C. gattii associated
with trees and with the soil, debris, and air around the trees.
Genotypic analysis revealed that virtually all environmental
and clinical isolates belong to the VGII genotype of C. gattii
(7). Studies using PCR fingerprinting, restriction fragment
length polymorphism (RFLP) analysis, and amplified fragment
length polymorphism (AFLP) analysis (7) identified two dis-
tinct genotypes among the isolates from Vancouver Island
(VGIIa/AFLP6a and VGIIb/AFLP6B), which were later sup-
ported by multilocus sequence typing (MLST) (4, 6). Given the
close proximity, climatic and geographic similarities to Van-
couver Island, and potential clinical importance, we have
sought to determine whether this pathogenic microbe has
spread to the Puget Sound area in the United States.
Firstly, in order to determine whether C. gattii had been
present in the Puget Sound region in Washington, we per-
formed a retrospective chart review of cases of cryptococcosis
from 1 January 1997 to 31 December 2004 at two large tertiary
Seattle hospitals, Harborview Medical Center and the Univer-
sity of Washington Medical Center. Patients were identified by
using discharge codes and were excluded if they had not lived
in the Puget Sound area in the 6 months before presentation
with cryptococcosis. Our second approach was to perform pro-
spective surveillance of cases of cryptococcosis at Harborview
Medical Center and University of Washington Medical Center,
starting in January 2005. Lastly, we performed environmental
sampling of trees, debris, and soil in the Puget Sound area,
using published methodology (7, 11). These studies were ap-
proved by the Fred Hutchinson Cancer Research Center insti-
tutional review board.
The retrospective chart review identified 49 new cases of
cryptococcosis; none were due to C. gattii. Prospective surveil-
lance from January 2005 identified one case of cryptococcosis
due to C. gattii in a 74-year-old man with a 5-year history of
large granular lymphocytic leukemia for which he was being
treated with oral prednisone, 2.5 mg daily, and intermittent
erythropoietin and pegfilgrastim. He presented in February
2006 with a cough. Radiology revealed a 13-mm lingular nod-
ule, and a thoracoscopic wedge resection was performed. The
histopathologic findings were consistent with an infectious pro-
cess, and C. gattii was isolated. RFLP and MLST analyses
confirmed that the isolate belongs to molecular type VGIIa,
the predominant C. gattii genotype in the Vancouver Island
emergence, and shares 100% nucleotide identity at 28 MLST
markers with the Vancouver Island major emergence clinical
reference isolate (A1MR265) (Fig. 1). Serum and cerebrospi-
nal fluid cryptococcal antigen titers were negative.
The patient lives on Orcas Island in the Puget Sound with his
wife. In the past year they had traveled to Southern California
and Hawaii. Their home is in a semirural setting with numer-
ous Douglas fir trees on the property. To determine whether C.
gattii has established itself in this locale, environmental sam-
pling was undertaken at his property. Sampling in April 2006 of
Douglas fir trees (n  366) and underlying soil/debris (n 
366) and of gardening soil (n  4) did not yield C. gattii.
We present a case of proven human cryptococcosis caused
by C. gattii, with confirmation of infection with the VGIIa
Vancouver Island emergence major genotype. While the pa-
tient had visited Los Angeles in the year before presentation,
and a single isolate of C. gattii identical to the VGIIa Vancou-
ver Island emergence major genotype was identified from an
environmental isolate in 1992 from the San Francisco area (4,
6, 10), we believe that acquisition on or near Orcas Island
provides a more parsimonious explanation than acquisition in
California. The incubation period from exposure to illness is
known to average 4 to 6 months, consistent with recent expo-
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sure, and he had not traveled to Vancouver Island or else-
where outside the United States. We have been unable to
isolate C. gattii from the environment around his home; there-
fore, the source of infection remains unclear. C. gattii may have
been transiently present in the area at the time of disease
acquisition or may be present below the limits of detection,
which is consistent with theories of recent dispersal (5, 8).
The expansion of the C. gattii niche beyond Vancouver Is-
land is further supported by recent accounts of human cases of
C. gattii infection without travel to Vancouver Island identified
on mainland British Columbia (9). In addition, C. gattii (geno-
typing pending) infection has been diagnosed in four porpoises
found washed up on Washington State beaches since 2004
(personal communication from Stephen Raverty, BC Depart-
ment of Veterinary Health). C. gattii infection has also been
diagnosed in three domestic cats from Whatcom County,
Washington State (9); isolates were determined to be the
VGIIa genotype based on analysis of DNA from formalin-
fixed, paraffin-embedded tissue. Insufficient material was re-
covered for MLST analysis, and thus, it is unknown whether
these isolates are molecularly identical to isolates from the
Vancouver Island emergence. Interestingly, C. gattii VGIIa
(identical to the Vancouver Island emergence major genotype)
isolates have been identified from soil and a fence post swab in
northern Washington in 2005 (9).
Two recent cases of C. gattii infection have been reported in
patients from Oregon State. Both were caused by VGII strains,
but based on six-marker MLST analysis, both are different
from the major (VGIIa) and minor Vancouver Island (VGIIb)
emergence genotypes (9). Thus, the relationship of these C.
gattii cases in Oregon to the Vancouver Island emergence is
unclear. In contrast, our patient’s isolate (T67707) belongs to
the VGIIa genotype, confirmed using RFLP and 28-marker
MLST. Thus, our patient is the first contemporary case of
human infection caused by the Vancouver Island emergence
strain within the United States. We note that a clinical isolate
(NIH444) obtained from a patient in Seattle in the 1970s is
also identical, based on MLST analysis, to the Vancouver Is-
land major emergence isolate, but no travel history is available
for this historical case (1, 4).
The Vancouver Island emergence is associated with the
highest reported incidence of human cryptococcosis in the
world, with significant morbidity and mortality (9). Continued
surveillance of human and veterinary cases and environmental
sampling in the Pacific Northwest are essential to provide more
understanding of this emerging infection.
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